Page last updated: 2024-09-03

n(6)-carboxymethyllysine and olmesartan medoxomil

n(6)-carboxymethyllysine has been researched along with olmesartan medoxomil in 1 studies

Compound Research Comparison

Studies
(n(6)-carboxymethyllysine)
Trials
(n(6)-carboxymethyllysine)
Recent Studies (post-2010)
(n(6)-carboxymethyllysine)
Studies
(olmesartan medoxomil)
Trials
(olmesartan medoxomil)
Recent Studies (post-2010) (olmesartan medoxomil)
80344365459119203

Protein Interaction Comparison

ProteinTaxonomyn(6)-carboxymethyllysine (IC50)olmesartan medoxomil (IC50)
ATP-binding cassette sub-family C member 3Homo sapiens (human)2
Bile salt export pumpHomo sapiens (human)4.73
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.9772
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.9772

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T1

Trials

1 trial(s) available for n(6)-carboxymethyllysine and olmesartan medoxomil

ArticleYear
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome

2012